E Fund Management Co., Ltd. Heron Therapeutics, Inc. Transaction History

E Fund Management Co., Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$2.32 - $3.86 $36,289 - $60,378	15,642 New	15,642 $54,000
Q3 2022 Nov 14, 2022	SELL	$2.66 - $5.37 $120,205 - $242,670	-45,190 Reduced 52.19%	41,391 $175,000
Q2 2022 Aug 15, 2022	BUY	$2.3 - $6.29 $89,281 - $244,165	38,818 Added 81.27%	86,581 $242,000
Q1 2022 May 12, 2022	BUY	$4.63 - $9.94 $136,103 - $292,196	29,396 Added 160.05%	47,763 $273,000
Q4 2021 Feb 11, 2022	BUY	$8.35 - $12.6 $29,742 - $44,881	3,562 Added 24.06%	18,367 $168,000
Q3 2021 Nov 12, 2021	BUY	$10.13 - $15.0 $67,060 - $99,300	6,620 Added 80.88%	14,805 $158,000
Q1 2021 May 12, 2021	BUY	$14.49 - $20.72 $118,600 - $169,593	8,185 New	8,185 $132,000

179

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.